Recurrent Periocular Basal Cell Carcinoma. Case Report

Pridavkova, Zuzana; Bieliková, A; Ferková, N; Lysková, Darina

doi:10.31348/2021/24

Cited by 3 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given the increasing global incidence of BCCs (i.e., 85-95%), especially the cases of eyelid malignant tumours, which can result in vision impairment and morbidity, collaboration among professional health care for the early prevention of eyelid malignant tumours [11,12]. It is vital to underscore the significance of interdisciplinary expertise.…”

Section: Introductionmentioning

confidence: 99%

Are we Capable of Contributing to the Reduction of Eyelid Basal Cell Carcinoma? Building a Healthcare Team

Ribeiro,

Bacalhau

2023

J Opht Res Rev Rep

View full text Add to dashboard Cite

Background: Basal cell carcinoma (BCC) is the most common malignant eyelid tumour encountered by oculoplastic surgeons (ophthalmologists), contributing significantly to morbidity. The objective of this study was to assess awareness levels and knowledge among healthcare professionals and the general public, regarding eyelid BCC, with a specific focus on the following areas: risk factors, prevention habits and pharmaceutical counseling. Methods: A cross-sectional survey study was employed for data collection. Anonymous surveys were distributed to two distinct groups: healthcare professionals (comprising physicians, pharmacists, and pharmacy students) and members of the general community in Setúbal. Data collection took place on a single day for each of these two groups. Results: The study encompassed 201 participants, consisting of 155 (77.1%) females (mean age = 42 years-old), and 44 (21.9%) males (mean age = 46 years-old). The survey revealed that 55.2% of respondents were unaware of the typical location of eyelid BCC. Furthermore, the majority of participants expressed consensus on the importance of applying sunscreen as a preventive measure. Conclusion: The study underscores the necessity for enhanced efforts in preventing eyelid BCC, emphasizing the crucial role of implementing protocols and educational initiatives targeting both healthcare professionals and the general public. These measures are essential to raise awareness, facilitate early detection, and enhance the management of eyelid BCC cases.

show abstract

Section: Introductionmentioning

confidence: 99%

Are we Capable of Contributing to the Reduction of Eyelid Basal Cell Carcinoma? Building a Healthcare Team

Ribeiro,

Bacalhau

2023

J Opht Res Rev Rep

View full text Add to dashboard Cite

show abstract

“…Non-melanoma skin tumours (NMSC) are the most widespread malignancies in the Caucasian population, with 18-20-times higher incidence than malignant melanoma and representing 5-10% of all skin tumours. [1]. The most common skin cancer is the basal cell carcinoma (BCC).…”

mentioning

confidence: 99%

Periocular basal cell carcinoma of the eyelids – review

et al. 2023

View full text Add to dashboard Cite

Introduction. Basal cell carcinoma is the most common tumour of the eyelids and periocular region throughout the world. BCC represents 90 % of malignant tumours of the eyelids, predominantly in the male population. The incidence is higher in age over 60. Over 50% of BCC of the periocular region initially occur on the lower lid and inner angle. Research objectives. Literature review of the epidemiology, aetiopathogenesis, clinical attributes, diagnostics, treatment histopathology, recurrence, prognostic factors, and management of BCC. Core of work. Standardised incidence of diagnosis C44 in the period 1997–2012 in Slovakia ranged from 35.05 to 73.9 cases per 100,000 inhabitants. The histopathological examination is essential. The first consideration for treatment of periocular BCC is radical surgical excision using Mohs micrographic technique. We can consider the apoptotic index, the expression of Bcl-2, as an unexplained prognostic factor of BCC recurrence. Conclusion. Increased attention must be given to periocular malignant tumours. Functional and aesthetic outcome in patients is important after clear excisions and reconstruction should be carefully considered. Radical exenteration is considered in the case of orbital invasion of high-risk aggressive BCC.

show abstract

Modern strategy and standards of treatment of lower eyelid skin malignant neoplasms

Polyakov

Давыдов

Ребрикова

et al. 2023

Ophthalmology Reports

View full text Add to dashboard Cite

Cases of surgical treatment of basal cell skin carcinoma of the lower eyelid are rarely described in the world literature. Perhaps this is due to the search for new non-surgical treatment methods or to the fact that this localization is poorly represented in the total incidence of basal cell skin cancer. However, the operative method, recommended as the main line of treatment by both domestic and foreign clinical recommendations, is still recognized as the most radical and aesthetically acceptable method of treatment. Non-radical treatment of the tumor leads, in turn, to relapses of the disease, to the emergence of systemic metastatic foci due to the lymphogenic and hematogenic spread of tumor cells. In the article we describe the experience of surgical treatment of patients suffering from basal cell skin carcinoma of the lower eyelid of varying degrees of extension.

show abstract

Recurrent Periocular Basal Cell Carcinoma. Case Report

Cited by 3 publications

References 17 publications

Are we Capable of Contributing to the Reduction of Eyelid Basal Cell Carcinoma? Building a Healthcare Team

Are we Capable of Contributing to the Reduction of Eyelid Basal Cell Carcinoma? Building a Healthcare Team

Periocular basal cell carcinoma of the eyelids – review

Modern strategy and standards of treatment of lower eyelid skin malignant neoplasms

Contact Info

Product

Resources

About